Table 1.
Target | Primer names | Sequences | Product length | GC% | Tm |
---|---|---|---|---|---|
RLEP | RLEP-F RLEP-R |
5`-TGCGCTAGAAGGTTGCCGTAT-3` 5`-ATTTCTGCCGCTGGTATCGGT-3` |
148 | 52.38 52.38 |
62.17 62.19 |
folP1 | folP1-F1 folP1R1 |
5` - CTTGATCCTGACGATGCTGT - 3` 5` - CCACCAGACACATCGTTGAC - 3` |
254 | 50.00 50.00 |
57.69 58.85 |
folP1 | folP1-F2 folP1-R2 |
5` - GATCCTGACGATGCTGTCCAG - 3` 5` - ACATCGTTGACGATCCGTG - 3` |
242 | 57.14 52.63 |
60.54 57.97 |
rpoB | rpoB-F1 rpoB-R1 |
5` - ACGCTGATCAATTATCCGTCC - 3` 5` - GTATTCGATCTCGTCGCTGA - 3` |
345 | 47.62 50.00 |
58.24 57.33 |
rpoB | rpoB-F2 rpoB-R2 |
5` - CTGATCAATATCCGTCCGGT - 3` 5` - CGACAATGAACCGATCAGAC - 3` |
255 | 50.00 50.00 |
56.89 56.65 |
gyrA | gyrA-F1 gyrA-R1 |
5` - ATGACTGATATCACGCTGCCA - 3` 5` - ATAACGCATCGCTGCCGGTGG - 3` |
390 | 47.62 61.90 |
59.59 65.97 |
gyrA | gyrA-F2 gyrA-R2 |
5`- GATGGTCTCAAACCGGTACATC - 3` 5` - ACCCGGCGAATTGAAATTG - 3` |
225 | 50.00 47.37 |
58.80 56.89 |
RLEP, Repetitive element; folP1, dapsone resistance-associated target; rpoB, rifampicin resistance-associated target; gyrA, quinolone resistance-associated target.